Profile | GDS5420 / 208932_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 1386.99 | 84 |
GSM1296119 | B_lesional_pre-dose | 688.47 | 73 |
GSM1296076 | C_lesional_pre-dose | 373.89 | 64 |
GSM1296092 | D_lesional_pre-dose | 730.45 | 74 |
GSM1296103 | E_lesional_pre-dose | 1807.61 | 88 |
GSM1296078 | F_lesional_pre-dose | 357.71 | 63 |
GSM1296107 | G_lesional_pre-dose | 853.58 | 77 |
GSM1296109 | H_lesional_pre-dose | 1506.34 | 86 |
GSM1296080 | I_lesional_pre-dose | 769.33 | 75 |
GSM1296090 | J_lesional_pre-dose | 521.78 | 69 |
GSM1296074 | K_lesional_pre-dose | 309.06 | 61 |
GSM1296111 | L_lesional_pre-dose | 626.95 | 72 |
GSM1296099 | M_lesional_pre-dose | 1132.5 | 81 |
GSM1296086 | O_lesional_pre-dose | 719.3 | 74 |
GSM1296117 | P_lesional_pre-dose | 779.09 | 75 |
GSM1296113 | Q_lesional_pre-dose | 730.75 | 74 |
GSM1296096 | R_lesional_pre-dose | 1313.1 | 83 |
GSM1296105 | S_lesional_pre-dose | 910.53 | 78 |
GSM1296098 | T_lesional_pre-dose | 1228.13 | 82 |
GSM1296101 | U_lesional_pre-dose | 1204.55 | 82 |
GSM1296121 | V_lesional_pre-dose | 827.91 | 76 |
GSM1296088 | W_lesional_pre-dose | 754 | 74 |
GSM1296082 | X_lesional_pre-dose | 626.3 | 72 |
GSM1296115 | Y_lesional_pre-dose | 965.57 | 79 |
GSM1296084 | Z_lesional_pre-dose | 600.19 | 71 |
GSM1296072 | B_lesional_day8 | 549.88 | 69 |
GSM1296069 | L_lesional_day8 | 534.05 | 68 |
GSM1296071 | P_lesional_day8 | 619.87 | 71 |
GSM1296070 | Y_lesional_day8 | 670.58 | 73 |
GSM1296073 | V_lesional_day8 | 728.63 | 74 |
GSM1296034 | A_lesional_day15 | 898.4 | 77 |
GSM1296041 | G_lesional_day15 | 809.97 | 76 |
GSM1296035 | R_lesional_day15 | 1255 | 82 |
GSM1296038 | U_lesional_day15 | 944.98 | 78 |
GSM1296047 | B_lesional_day15 | 491.6 | 67 |
GSM1296039 | E_lesional_day15 | 756.8 | 75 |
GSM1296042 | H_lesional_day15 | 602.68 | 71 |
GSM1296043 | L_lesional_day15 | 690.69 | 73 |
GSM1296037 | M_lesional_day15 | 633.75 | 71 |
GSM1296046 | P_lesional_day15 | 483.06 | 67 |
GSM1296044 | Q_lesional_day15 | 495.25 | 67 |
GSM1296045 | Y_lesional_day15 | 516.07 | 68 |
GSM1296025 | C_lesional_day15 | 175.18 | 51 |
GSM1296033 | D_lesional_day15 | 486.45 | 67 |
GSM1296027 | I_lesional_day15 | 157.33 | 50 |
GSM1296032 | J_lesional_day15 | 336.83 | 61 |
GSM1296024 | K_lesional_day15 | 159.71 | 49 |
GSM1296031 | W_lesional_day15 | 533.71 | 68 |
GSM1296028 | X_lesional_day15 | 301.82 | 59 |
GSM1296029 | Z_lesional_day15 | 492.91 | 67 |
GSM1296026 | F_lesional_day15 | 242.86 | 56 |
GSM1296030 | O_lesional_day15 | 444.3 | 66 |
GSM1296040 | S_lesional_day15 | 1494.97 | 85 |
GSM1296036 | T_lesional_day15 | 1087.18 | 81 |
GSM1296048 | V_lesional_day15 | 733.21 | 74 |
GSM1296059 | A_lesional_day43 | 1632.31 | 86 |
GSM1296066 | G_lesional_day43 | 679.85 | 73 |
GSM1296060 | R_lesional_day43 | 978.47 | 79 |
GSM1296063 | U_lesional_day43 | 615.23 | 71 |
GSM1296064 | E_lesional_day43 | 951.82 | 78 |
GSM1296067 | H_lesional_day43 | 667.67 | 72 |
GSM1296062 | M_lesional_day43 | 1193.66 | 82 |
GSM1296068 | Q_lesional_day43 | 416.04 | 64 |
GSM1296050 | C_lesional_day43 | 230.51 | 55 |
GSM1296057 | D_lesional_day43 | 661.65 | 72 |
GSM1296052 | I_lesional_day43 | 146.47 | 49 |
GSM1296054 | J_lesional_day43 | 370.01 | 62 |
GSM1296049 | K_lesional_day43 | 257.75 | 57 |
GSM1296055 | W_lesional_day43 | 612.53 | 71 |
GSM1296053 | X_lesional_day43 | 287.95 | 58 |
GSM1296058 | Z_lesional_day43 | 892.6 | 77 |
GSM1296051 | F_lesional_day43 | 430.02 | 66 |
GSM1296056 | O_lesional_day43 | 1080.38 | 80 |
GSM1296065 | S_lesional_day43 | 620.78 | 71 |
GSM1296061 | T_lesional_day43 | 1064.62 | 80 |
GSM1296095 | A_non-lesional_pre-dose | 775.38 | 75 |
GSM1296120 | B_non-lesional_pre-dose | 491.06 | 67 |
GSM1296077 | C_non-lesional_pre-dose | 162.41 | 50 |
GSM1296093 | D_non-lesional_pre-dose | 446.44 | 65 |
GSM1296104 | E_non-lesional_pre-dose | 663.07 | 73 |
GSM1296079 | F_non-lesional_pre-dose | 280.93 | 59 |
GSM1296108 | G_non-lesional_pre-dose | 548.84 | 69 |
GSM1296110 | H_non-lesional_pre-dose | 593.86 | 70 |
GSM1296081 | I_non-lesional_pre-dose | 198.01 | 53 |
GSM1296091 | J_non-lesional_pre-dose | 325.27 | 61 |
GSM1296075 | K_non-lesional_pre-dose | 174.96 | 52 |
GSM1296112 | L_non-lesional_pre-dose | 476.95 | 66 |
GSM1296100 | M_non-lesional_pre-dose | 660.54 | 72 |
GSM1296087 | O_non-lesional_pre-dose | 131.72 | 48 |
GSM1296118 | P_non-lesional_pre-dose | 427.42 | 64 |
GSM1296114 | Q_non-lesional_pre-dose | 448.29 | 65 |
GSM1296097 | R_non-lesional_pre-dose | 768.59 | 75 |
GSM1296106 | S_non-lesional_pre-dose | 633.55 | 71 |
GSM1296102 | U_non-lesional_pre-dose | 666.13 | 72 |
GSM1296122 | V_non-lesional_pre-dose | 498.01 | 68 |
GSM1296089 | W_non-lesional_pre-dose | 337.91 | 60 |
GSM1296083 | X_non-lesional_pre-dose | 349.95 | 61 |
GSM1296116 | Y_non-lesional_pre-dose | 474.61 | 66 |
GSM1296085 | Z_non-lesional_pre-dose | 241.96 | 56 |